BMRA Live signals | Maximize Profits with Getagraph.com

SELL 108634 min ago

@ $0.940

Issued: 9 Feb 2024 @ 14:05

Return: -24.15%

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Stats
Today's Volume	658 345
Average Volume	57 991.00
Market Cap	11.99M
EPS	$0 ( 2024-04-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.930
ATR14	$0.00700 (1.01%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Coste Catherine	Buy	75 000	Non-qualified stock option
2023-12-13	Moatazedi David	Buy	75 000	Non-qualified stock option
2023-12-13	Kenny John P.	Buy	75 000	Non-qualified stock option
2023-12-13	Emerson Jane	Buy	75 000	Non-qualified stock option
2023-12-13	Lu Gary	Buy	155 000	Non-qualified stock option

INSIDER POWER
100.00
Last 96 transactions
Buy: 2 712 565 \| Sell: 242 000

Volume Correlation

Long: 0.48 (neutral)

Short: -0.57 (weak negative)

Signal:(47.776) Neutral

Biomerica Inc Correlation

10 Most Positive Correlations
AVGR	0.967
ARVL	0.967
FCBC	0.962
USEG	0.96
ISUN	0.959
ATNF	0.958
CMBM	0.957
SEV	0.957
PMVP	0.957
CAAS	0.956

10 Most Negative Correlations
MLAI	-0.976
TCMD	-0.974
OXUS	-0.973
TZPS	-0.971
IPAR	-0.969
CBRG	-0.966
BIOT	-0.966
ORIA	-0.964
TZPSU	-0.963
BIOS	-0.962

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biomerica Inc Correlation - Currency/Commodity

0.65
( weak )

0.66
( moderate )

0.00
( neutral )

0.59
( weak )

-0.34
( neutral )

0.01
( neutral )

Biomerica Inc Financials

Annual	2023
Revenue:	$5.34M
Gross Profit:	$446 000 (8.35 %)
EPS:	$-0.500

Q3	2024
Revenue:	$1.02M
Gross Profit:	$-149 001 (-14.65 %)
EPS:	$-0.110

Q2	2024
Revenue:	$1.57M
Gross Profit:	$325 000 (20.74 %)
EPS:	$-0.0896

Q1	2024
Revenue:	$1.71M
Gross Profit:	$412 000 (24.05 %)
EPS:	$-0.0673

Financial Reports:

No articles found.

Biomerica Inc

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.